FDA reverses stance on autism drug
The US Food and Drug Administration is no longer recommending a high-dose B vitamin medication (leucovorin) as a potential treatment for autism. Last fall, Health and Human Services Secretary Robert Kennedy Jr. claimed the drug could be a therapy for thousands of children with the condition.
March 11, 2026
Power outages disrupt storm preparations for Hawaii residents
St. Patrick's Day Weekend 2026: What you need to know about parades, Chicago River dyeing, and more
Trump seeks to replace White House visitor screening center with underground facility
Formula 1 calls off April races in Bahrain and Saudi Arabia due to Iran war
Another 3 members of Iran's women's soccer team decide against staying in Australia as refugees
Anti-war protests in Italy and Spain as high-stakes referendum on Italian judges looms
US Energy secretary directs oil company to restore operations off California
Shea Langeliers homers 3 times for the Athletics against the Kansas City Royals